Biomedical Science and Biotechnology
The Biomedical Science and Biotechnology R&D Cluster will capitalize on UAlbany’s internationally recognized strength in Life Sciences to pursue advances in areas of neurodegenerative diseases and neurodevelopment, infectious disease, and cancer, expanding existing partnerships and growing new relationships with the pharmaceutical and biotechnology industries. Key features will include:
- Building upon the transformational RNA Institute - the only resource of its kind in the world and the cornerstone of the University’s Life Sciences Initiative. Ranked #2 in the Governor’s Regional Economic Development Council (REDC) competition for the Capital Region, the RNA Institute leverages innovative tools, instrumentation and technologies for RNA science to create innovative solutions for difficult‐to‐treat diseases.
- Providing shared infrastructure in advanced research facilities with state of the art equipment, enabling researchers to form collaborations with both emerging biotech companies and larger established companies
- Partnering with regional hospitals and healthcare networks to carry out clinical trials for noninvasive diagnostics for infectious diseases, cancers and neurodegenerative diseases including Alzheimer’s and Parkinson’s (with the Stratton VA Medical Center), which could lead to the development of a service center for testing and new jobs for highly qualified biotech or medical technicians.
- Creating a pipeline of well-trained, highly-skilled workers to support the life science and biotech businesses, as well as attracting new partners to collaborate and co-locate. Together with the Neural Stem Cell Institute, the Trudeau Institute, Wadsworth Center Laboratories, and community colleges, this R&D cluster will provide training of entrepreneurial, scientists and project managers to support the local biotech sector.